Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-09-27

FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for risperidone, granting approval of a generic risperidone product. This is a supplemental appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)